STRATA CRITICAL MEDICAL, INC. Impairment of Intangible Assets (Excluding Goodwill)
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2025-08-05
- STRATA CRITICAL MEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2024-09-30 was $0.00.
- STRATA CRITICAL MEDICAL, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2024-06-30 was $5.76M.
- STRATA CRITICAL MEDICAL, INC. impairment of intangible assets (excluding goodwill) for fiscal 2024 was $5.76M, a 72.25% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. impairment of intangible assets (excluding goodwill) for fiscal 2023 was $20.75M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $5.76M derived: sum of 3 quarters · filed 2025-08-05 | $5.76M 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $5.76M derived: sum of 2 quarters · filed 2025-08-05 | $5.76M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $5.76M 10-Q · filed 2025-08-05 | $5.76M 10-Q · filed 2025-08-05 | ||
| 2023-12-31 | $20.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $20.75M derived: sum of 2 quarters · filed 2025-03-13 | $20.75M derived: sum of 3 quarters · filed 2025-03-13 | $20.75M 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |